Starpharma Holdings Ltd

Research Starpharma Holdings Ltd (SPL) on Bullrun: market cap AUD 294.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSPL
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyAUD
• Market capAUD 294.80M
• Financial periodFY2025
• RevenueAUD 4.91M
• Revenue growth-40.7%
• Net income-AUD 9.99M
• Free cash flow-AUD 6.80M
• Gross margin75.1%

Valuation Snapshot

latest market cap is AUD 294.80M.

About Starpharma Holdings Ltd

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating.

Frequently asked questions

What is Starpharma Holdings Ltd's market cap?

Starpharma Holdings Ltd's market capitalization is AUD 294.80M.

What does Starpharma Holdings Ltd do?

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.